Clinical Trial Update: A Study to Investigate the Effect of JNJ-42847922 on Polysomnography Measures in Patients With Major Depressive Disorder With Insomnia Who Are Stably Treated With Antidepressants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating how JNJ-42847922 affects polysomnography measures in adults with major depressive disorder and insomnia who remain on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia
• Major Depressive Disorder

Drugs mentioned

• JNJ-42847922

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Depressive Disorder, Major | Phase 1 | Status: COMPLETED